Investor Update: Chaarat Gold Updates BFS for Tulkubash Gold Prospect



[ad_1]

Key News from the Proactive Investors UK Newsroom:

The lung cancer diagnosis of Oncimmune Holdings PLC (LON: ONC) has achieved its main goal, namely a reduction in the number of people diagnosed with advanced lung cancer in a large NHS study in Scotland. The study was conducted among 12,210 patients. It is believed to be the largest randomized controlled study using biomarkers for the detection of lung cancer.

Chaarat Gold (LON: CGH) has updated its feasibility study for the Tulkubash gold potential. Based on an average annual production of 94,000 ounces and a cash cost of $ 678 per ounce, the net present value stands at $ 70 million. The estimated cost of building the mine also dropped to US $ 110 million.

Horizonte Mineral's (LON: HZM) boss, Jeremy Martin, praised the production of high-purity nickel and cobalt sulphate as part of the test work on their Vermelho project. The results will be incorporated into the project pre-feasibility study.

High-level fund manager Neil Woodford was forced to suspend operations on his flagship vehicle due to a wave of redemptions. Investors have withdrawn approximately £ 560 million from the Woodford Equity Income Fund over the last four weeks.

Shell will increase the amount of its dividends and buybacks after announcing that the company would generate more cash than expected. Organic free cash flow will now be around $ 35 billion in 2025 at an oil price of $ 60 per barrel, providing the opportunity to distribute $ 125 billion or more to shareholders over a five-year period from 2021-2025.

[ad_2]
Source link